Deal of the Day — limited-time pharmacy picks!
Carbocine 450mg\45ml Injection

Carbocine 450mg\45ml Injection

Salt Composition: Carboplatin

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

▼

1 injection

About The Product

Ovaries Cancer,Lung cancer

Description

Carbocine 450mg/45ml Injection is a prescription based medication used in the treatment of ovarian and non small cell lung cancer. Its active ingredient is Carboplatin which belongs to the drug class of platinum- based antineoplastic (chemotherapy) agents.

It works by damaging the cancer cells DNA strands through which DNA is damaged and cancer cells can die. The medicine is effective for the rapid growing of cancer cells in the body.

The exact dose and dosage is only mainstreamed by the healthcare professional.

Indication

  • Ovarian cancer and non small cell lung cancer

Common Side Effects

Every medication shows some side effects. Patient experience mild as well as severe side effects while using Carbocine 450mg Injection. Cosult the doctor before using the medication to avoid complications during the treatment. Common ones include:

  • Loss of taste, diarrhea
  • Constipation
  • Hair loss
  • Skin rashes
  • Itchiness
  • Extreme tiredness and weakness

  • Reduced number of red blood cells (anemia)
  • Allergic reactions
  • Abnormal bruises
  • Kidney problems
  • Hearing problems
  • Fever, chills

  • Inflammation in lung tissues
  • Tingling or numbness in your hands, arms, or legs
  • Prickling sensation

Dosage And Duration

  • Carbocine 45ml Injection should be taken into the veins under the medical supervision of a healthcare professional. It must be taken at the same time everyday to improve the effectiveness of the medication.
  • Do not miss or stop taking the injection without consultation with a doctor, as doing so may affect the effectiveness of the therapy and the overall treatment outcome.

Mechanism Of Action

  • Carbocine 450mg Injection is a platinum based chemotherapy drug. It works by damaging cancer cells' DNA strands which stops them from diving and growing.
  • This DNA damaged cannot be repaired properly, leading to the death of cancer cells through programmed cell death (apoptosis). By targeting it, the medicine reduces tumor growth and prevents the spread of cancer in the body.

Safety Advice

Alcohol
Taking Carbocine 450mg Injection with alcohol is may be dangerous to the patient health but consult the doctor before taking the medication.
Driving
Carbocine 450mg Injection may not cause dizziness or sleepiness but patient may still experience some side effects. It is important to monitor the response of medication and report any unusual symptoms to the doctor.
Pregnancy
Carbocine 450mg Injection is not recommended to pregnant and breastfeeding women as it may affect the fetus or newborn. Take guidance from a healthcare expert to ensure safety and precautions.
Kidney
Kidney patients should take precautions while using Carbocine 450mg Injection as dose adjustment and doctor's prescription is much needed.
Breastfeeding
BreastfeedingBreastfeeding women should not be advisable for taking Carbocine 450mg Injection as the medicine is passed through breast that somehow affect breast milk. Discuss with the doctor for more query.
Liver
Carbocine 450mg is not suitable for liver patients as data suggest it affect the kidney function. Consult the doctor for more information.

Faqs

Carbocine 450mg Injection is an anti-cancer medication is used in the treatment of ovarian and non small cell lung cancer by blocking the DNA mutated strands which is responsible for the growth of cancer cells in the body.

References

  • Stewart, D. J. (2007). Mechanisms of resistance to cisplatin and carboplatin. Critical reviews in oncology/hematology, 63(1), 12-31. https://pubmed.ncbi.nlm.nih.gov/17336087/
  • van der Vijgh, W. J. (1991). Clinical pharmacokinetics of carboplatin. Clinical pharmacokinetics, 21(4), 242-261. https://pubmed.ncbi.nlm.nih.gov/1760899/
  • Canetta, R., Rozencweig, M., & Carter, S. K. (1985). Carboplatin: the clinical spectrum to date. Cancer treatment reviews, 12, 125-136. https://pubmed.ncbi.nlm.nih.gov/3002623/
  • Fox, L. E. (2000). Carboplatin. Journal of the American Animal Hospital Association, 36(1), 13-14. https://pubmed.ncbi.nlm.nih.gov/10667400/
  • Go, R. S., & Adjei, A. A. (1999). Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin. Journal of Clinical Oncology, 17(1), 409-409.

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026